Attached files
| file | filename |
|---|---|
| EX-10.9 - EX-10.9 - Spero Therapeutics, Inc. | spro-ex109_1873.htm |
| EX-32.2 - EX-32.2 - Spero Therapeutics, Inc. | spro-ex322_9.htm |
| EX-32.1 - EX-32.1 - Spero Therapeutics, Inc. | spro-ex321_8.htm |
| EX-31.2 - EX-31.2 - Spero Therapeutics, Inc. | spro-ex312_7.htm |
| EX-31.1 - EX-31.1 - Spero Therapeutics, Inc. | spro-ex311_6.htm |
| EX-21.1 - EX-21.1 - Spero Therapeutics, Inc. | spro-ex211_429.htm |
| 10-K - 10-K - Spero Therapeutics, Inc. | spro-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (No. 333- 222060) of Spero Therapeutics, Inc. of our report dated April 2, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
April 2, 2018